Caspase-1 regulates the inflammatory process leading to autoimmune demyelination

Journal of Immunology

Volumn 163, Issue 5, 1999, Pages 2403-2409

  Furlan, Roberto ^a   Martino, Gianvito ^a   Galbiati, Francesca ^b   Poliani, Pietro L ^a   Smiroldo, Simona ^b   Bergami, Alessendra ^a   Desina, Gaetano ^a,c   Comi, Giancarlo ^a   Flavell, Richard ^d   Su, Michael S ^e   Adorini, Luciano ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b ROCHE MILANO RICERCHE   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MYELIN ASSOCIATED GLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DEMYELINATION; FEMALE; HELPER CELL; IMMUNIZATION; INCIDENCE; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TISSUE HOMOGENATE;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; AUTOIMMUNE DISEASES; CASPASE 1; CYSTEINE PROTEINASE INHIBITORS; DISEASE SUSCEPTIBILITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOSUPPRESSIVE AGENTS; INFUSION PUMPS, IMPLANTABLE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN SHEATH; NEUROPROTECTIVE AGENTS; RNA, MESSENGER; SPINAL CORD; TH1 CELLS; UP-REGULATION;

EID: 0033198269     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Thornberry, N. A., and Y. Lazebnik. 1998. Caspases: enemies within. Science 281:1312.
2. Wang, S., M. Miura, Y. Jung, H. Zhu, E. Li, and J. Yuan. 1998. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92:501.
3. McAlidon, M. E., C. J. Hawkey, and Y. R. Mahida. 1998. Expression of interleukin-1β and interleukin-1β converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut 42:214.
4. Tingsborg, S., M. Zetterstrom, K. Alheim, H. Hasanvan, M. Schultzberg, and T. Bartfai. 1996. Regionally specific induction of ICE mRNA and enzyme activity in the rat brain and adrenal gland by LPS. Brain Res. 712:153.
5. Kuida, K., J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S. Su, and R. A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267:2000.
6. Gu, Y., K. Kuida, H. Tsutsui, G. Ku, K. Hsiao, M. A. Fleming, N. Hayashi, K. Higashino, H. Okamura, K. Nakanishi, et al. 1997. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science 275:206.
7. Li, P., H. Allen, S. Banerjee, and T. Seshadri. 1997. Characterization of mice deficient in interleukin-1β converting enzyme. J. Cell. Biochem. 64:27.
8. Norman, J., J. Yang, G. Fink, G. Carter, G. Ku, W. Denham, and D. Livingston. 1997. Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). J. Interferon Cytokine Res. 17:113.
9. Rouquet, N., J. C. Pages, T. Molina, P. Briand, and V. Joulin. 1996. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr. Biol. 6:1192.
10. Ku, G., T. Faust, L. L. Lauffer, D. J. Livingston, and M. W. Harding. 1996. Interleukin-1β converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice. Cytokine 8:377.
11. Martin, R., H. F. McFarland, and D. E. McFarlin. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:153.
12. Steinman, L. 1996. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc. Natl. Acad. Sci. USA 93:2253.
13. Martino, G., F. Grohovaz, E. Brambilla, F. Codazzi, A. Consiglio, E. Clementi, M. Filippi, G. Comi, and L. M. E. Grimaldi. 1998. Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients. Ann. Neurol. 43:340.
14. Beck, J., P. Rondot, L. Catinot, E. Falcoff, H. Kirchner, and J. Wietzerbin. 1988. Increased production of interferon y and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol. Scand. 78:318.
15. Panitch, H. S., R. L. Hirsch, A. S. Haley, and K. P. Johnson. 1987. Exacerbations of multiple sclerosis in patients treated with y interferon. Lancet 1:893.
16. Brosnan, C. F., B. Cannella, L. Battistini, and C. S. Raine. 1995. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology 45:S16.
17. Martin, D., and S. L. Near. 1995. Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 61:241.
18. Zhu, H., H. O. Fearnhead, and G. M. Cohen. 1995. An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP-1 cells. FEBS Lett. 374:303.
19. Rodriguez, I., K. Matsuura, C. Ody, S. Nagata, and P. Vassalli. 1996. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med. 184:2067.
20. Openshaw, P., E. E. Murphy, N. A. Hosken, V. Maino, K. Davis, K. Murphy, and A. O'Garra. 1995. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182: 1357.
21. Galbiati, F., L. Rogge, J. C. Guery, S. Smiroldo, and L. Adorini. 1998. Regulation of the IL-12 receptor β-2 subunit by soluble antigen and IL-12 in vivo. Eur. J. Immunol. 28:209.
22. Piddlesden, S. J., M. K. Storch, M. Hibbs, A. M. Freeman, H. Lassmann, and B. P. Morgan. 1994. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 152:5477.
23. Eugster, H-P., K. Frei, M. Kopf, H. Lassmann, and A. Fontana. 1998. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:2178.
24. b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Ear. J. Immunol. 25:1951.
25. O'Neil, J. K., D. Baker, A. N. Davison, K. K. Maggon, B. D. Jaffee, and J. L. Turk. 1992. Therapy of chronic relapsing experimental allergic encephalomyelitis and the role of the blood-brain barrier: elucidation by the action of Brequinar sodium. J. Neuroimmunol. 38:53.
26. Livingston, D. J. 1997. In vitro and in vivo studies of ICE inhibitors. J. Cell. Biochem. 64:19.
27. Olsson, T. 1995. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:245.
28. Ewing, C., and C. C. Bernard. 1998. Insights into the aetiology and pathogenesis of multiple sclerosis. Immunol. Cell. Biol. 76:47.
29. Ruuls, S. R., and J. D. Sedgwick. 1998. Cytokine-directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis. Immunol. Cell. Biol. 76:65.
30. Jander, S., and G. Stoll. 1998. Differential induction of interleukin-12, interleukin-18 and interleukin-1β converting enzyme mRNA in experimental autoimmune encephalomyelitis of the Lewis rat. J. Neuroimmunol. 91:93.
31. + T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J. Immunol. 159:97.
32. Robinson, D., K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S. B. Hartley, S. Menon, R. Kastelein, F. Bazan, and A. O'Garra. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity 7:571.
33. Gately, M. K., L. M. Renzetti, J. Magram, A. S. Stern, L. Adorini, U. Gubler, and D.H. Presky. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:495.
34. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383.
35. Szabo, S. J., A. S, Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th 1) and Th2 cells. J. Exp. Med. 185:817.
36. Fantuzzi, G., G. Ku, M. W. Harding, D. J. Livingston, J. D. Sipe, K. Kuida, R. A. Flavell, and C. A. Dinarello. 1997. Response to local inflammation of IL-1β-converting enzyme-deficient mice. J. Immunol. 158:1818.
37. Schulz, J. B., M. Weller, and M. A. Moskowitz. 1999. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann. Neurol. 45:421.